InsiderTrades.com logo
Why Big Pharma is Investing Billions in This Biotech
From Behind the Markets   |   Ad
If you're on the hunt for a great biotech stock under $20... you need to see this video.
Watch my exclusive report here>>>
Bill McMurray net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Bill McMurray Biography and Net Worth

CRO of Qualtrics International
William B. McMurray is the Chief Revenue Officer at Qualtrics International.

What is Bill McMurray's net worth?

The estimated net worth of Bill McMurray is at least $14.63 million as of June 1st, 2023. Mr. McMurray owns 806,422 shares of Qualtrics International stock worth more than $14,628,495 as of April 27th. This net worth approximation does not reflect any other investments that Mr. McMurray may own. Learn More about Bill McMurray's net worth.

How do I contact Bill McMurray?

The corporate mailing address for Mr. McMurray and other Qualtrics International executives is 333 WEST RIVER PARK DRIVE, PROVO UT, 84604. Qualtrics International can also be reached via phone at 385-203-4999 and via email at [email protected]. Learn More on Bill McMurray's contact information.

Has Bill McMurray been buying or selling shares of Qualtrics International?

Bill McMurray has not been actively trading shares of Qualtrics International in the last ninety days. Most recently, Bill Mcmurray sold 15,000 shares of the business's stock in a transaction on Thursday, June 1st. The shares were sold at an average price of $18.06, for a transaction totalling $270,900.00. Following the completion of the sale, the executive now directly owns 806,422 shares of the company's stock, valued at $14,563,981.32. Learn More on Bill McMurray's trading history.

Who are Qualtrics International's active insiders?

Qualtrics International's insider roster includes Robert Bachman (CFO), Chris Beckstead (President), Bill McMurray (CRO), Zig Serafin (CEO), Ryan Smith (Insider), Brian Stucki (Insider), and John Thimsen (CTO). Learn More on Qualtrics International's active insiders.

Are insiders buying or selling shares of Qualtrics International?

During the last year, insiders at the sold shares 7 times. They sold a total of 570,100 shares worth more than $10,210,477.66. The most recent insider tranaction occured on June, 26th when insider Brian Stucki sold 12,000 shares worth more than $217,680.00. Insiders at Qualtrics International own 12.5% of the company. Learn More about insider trades at Qualtrics International.

Information on this page was last updated on 6/26/2023.

Bill McMurray Insider Trading History at Qualtrics International

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/1/2023Sell15,000$18.06$270,900.00806,422View SEC Filing Icon  
See Full Table

Bill McMurray Buying and Selling Activity at Qualtrics International

This chart shows Bill Mcmurray's buying and selling at Qualtrics International by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Qualtrics International Company Overview

Qualtrics International logo
Qualtrics International Inc. operates an experience management platform to design and manage customer, employee, product, and brand experiences worldwide. The company offers The Qualtrics Experience Management Platform, a system of action that guides users with specific instructions for improvement and automated actions to improve experiences. It also provides professional services that primarily consist of research services, through its DesignXM, which allows customers to gain market intelligence, as well as implementations, configurations, and integration and engineering services to help customers deploy its XM Platform. Qualtrics International Inc. was founded in 2002 and is headquartered in Provo, Utah. Qualtrics International Inc. is a subsidiary of SAP America, Inc.
Read More

Today's Range

Now: $18.14
Low: $18.14
High: $18.14

50 Day Range

MA: $18.11
Low: $18.04
High: $18.14

2 Week Range

Now: $18.14
Low: $9.32
High: $18.15

Volume

N/A

Average Volume

4,000,243 shs

Market Capitalization

$11.00 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.73
Why Big Pharma is Investing Billions in This Biotech
From Behind the Markets   |   Ad
If you're on the hunt for a great biotech stock under $20... you need to see this video.
Watch my exclusive report here>>>